Login

Matt Brown, CFO of Livetiles Ltd (ASX: LVT), discussed with Satori Fund's Founder Dan Niles about energy prices being a significant concern. 00:10:00

Share On Facebook Share On Twitter

LiveTiles is managed by CEO David Vander.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Navigating Special Situations: Insights from Kotak Special Opportunities Fund | Shibani Kurian - Senior Fund Manager, Kotak Mutual Fund
00:10:00
Tim Heenan, Interim President at Mirasol Resources: Company Overview and Exploration Focus
00:10:00
Pioneering Sustainability and Leading Global Change | Hakan Bulgurlu, CEO, Arçelik AS.
00:10:00
Join Elizabeth Burton, MD & Client Investment Strategist at Goldman Sachs Asset Management, as she navigates the complexities of the fundraising climate.
00:10:00
BBVA's Successful Year: Growth, Profitability, and Societal Impact | Carlos Torres Vila , President , BBVA .
00:10:00
Backs bold entrepreneurs building the future through technology|Arianna Simpson,General Partner,Andreessen Horowitz
00:10:00
Exploring the Best Arbitrage Mutual Funds of 2024: Insights and Comparisons
00:10:00
FieldPoint Petroleum Corporation and Cimarex Energy: Joint Operating Agreement Update
00:10:00
"RIT Capital Partners: Leveraging Centuries of Financial Expertise for Modern Investment Mastery"
00:10:00
Dr. Desmond FitzGerald discusses how Intrepid Geophysics leveraged AWS to innovate, attract customers, and overcome challenges in their cloud journey.| Dr Jeff Keetley is the CEO of Intrepid Geophysics
00:10:00
The Quincy Institute and America's Foreign Policy|Andrew Bacevich,Professor,Boston University
00:10:00
"Stephen Yacktman Discusses Strategies for High Valuation Markets: Insights from Yacktman Asset Management"

© 2017 - Neuhu+